2015
DOI: 10.1097/aog.0000000000001064
|View full text |Cite
|
Sign up to set email alerts
|

Obstetric Surgical Site Infections

Abstract: III.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 108 publications
(14 citation statements)
references
References 11 publications
0
13
0
1
Order By: Relevance
“…In evaluating the effectiveness of vac dressings, the primary goal was to assess the presence of a superficial incisional surgical site infection (SSI). Eleven studies assessed the use of cefazolin in perioperative prophylaxis [48][49][50][51][52][53][54][55][56][57][58], six of which were prospective [48,52,[54][55][56][57][58], and two were randomized and double-blind [51,53].…”
Section: Characteristics Of Included Studiesmentioning
confidence: 99%
“…In evaluating the effectiveness of vac dressings, the primary goal was to assess the presence of a superficial incisional surgical site infection (SSI). Eleven studies assessed the use of cefazolin in perioperative prophylaxis [48][49][50][51][52][53][54][55][56][57][58], six of which were prospective [48,52,[54][55][56][57][58], and two were randomized and double-blind [51,53].…”
Section: Characteristics Of Included Studiesmentioning
confidence: 99%
“… 41 Several recent studies comparing preoperative 2 g with 3 g cefazolin in morbidly obese gravid women before cesarean section found no difference in the rate of SSI or in the adipose tissue antibiotic concentration between the two regimens. 42 44 One trial did find higher adipose concentrations of cefazolin after administration of 3 g but did not evaluate the effect on SSI occurrence. 45 The American College of Obstetricians and Gynecologists, in its committee opinion, recommends antimicrobial prophylaxis for all cesarean deliveries unless the patient is already receiving an antibiotic regimen with appropriate coverage (eg, for chorioamnionitis).…”
Section: Prevention Strategiesmentioning
confidence: 99%
“…For women with (BMI >30 kg/m 2 or weight > 100 kg, a dose of 2 g cefazolin intravenous infusion is recommended [40]. Though use of higher doses have been considered in women with BMI > 40 kg/m 2 , one retrospective study of morbidly obese women did not demonstrate a difference in SSIs comparing cefazolin doses of 2 g and 3 g [41]. …”
Section: Preoperative Managementmentioning
confidence: 99%